HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 272 filers reported holding HAEMONETICS CORP in Q3 2022. The put-call ratio across all filers is 1.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $406,866 | -44.6% | 4,918 | -42.9% | 0.01% | -54.5% |
| Q1 2024 | $735,034 | -64.1% | 8,612 | -64.0% | 0.01% | -71.1% |
| Q4 2023 | $2,046,254 | -13.9% | 23,930 | -9.8% | 0.04% | -22.4% |
| Q3 2023 | $2,375,482 | +31.8% | 26,518 | +25.3% | 0.05% | +25.6% |
| Q2 2023 | $1,802,073 | +190.4% | 21,166 | +182.3% | 0.04% | +160.0% |
| Q1 2023 | $620,460 | -32.5% | 7,498 | -35.8% | 0.02% | -42.3% |
| Q4 2022 | $919,025 | +141.2% | 11,685 | +127.2% | 0.03% | +136.4% |
| Q3 2022 | $381,000 | +13.7% | 5,143 | -0.0% | 0.01% | 0.0% |
| Q2 2022 | $335,000 | -2.0% | 5,144 | -20.3% | 0.01% | 0.0% |
| Q4 2021 | $342,000 | -28.8% | 6,453 | -5.0% | 0.01% | -42.1% |
| Q3 2021 | $480,000 | -19.9% | 6,794 | +1.6% | 0.02% | +5.6% |
| Q2 2020 | $599,000 | -71.7% | 6,684 | -68.6% | 0.02% | -69.5% |
| Q1 2020 | $2,119,000 | +277.0% | 21,266 | +335.0% | 0.06% | +490.0% |
| Q4 2019 | $562,000 | -65.6% | 4,889 | -73.8% | 0.01% | -58.3% |
| Q1 2019 | $1,632,000 | -55.6% | 18,653 | -49.3% | 0.02% | -57.9% |
| Q4 2018 | $3,678,000 | -29.7% | 36,764 | -19.5% | 0.06% | -20.8% |
| Q3 2018 | $5,233,000 | +5.2% | 45,667 | -17.7% | 0.07% | 0.0% |
| Q2 2018 | $4,975,000 | -55.9% | 55,472 | -64.1% | 0.07% | -54.4% |
| Q1 2018 | $11,292,000 | +674.0% | 154,341 | +514.3% | 0.16% | +652.4% |
| Q4 2017 | $1,459,000 | -41.5% | 25,123 | -54.8% | 0.02% | -43.2% |
| Q3 2017 | $2,493,000 | +68.4% | 55,561 | +48.3% | 0.04% | +76.2% |
| Q2 2017 | $1,480,000 | +130.9% | 37,473 | +137.1% | 0.02% | +162.5% |
| Q1 2017 | $641,000 | -44.1% | 15,808 | -60.1% | 0.01% | -42.9% |
| Q2 2016 | $1,147,000 | -21.4% | 39,575 | +12.2% | 0.01% | +16.7% |
| Q2 2015 | $1,459,000 | +332.9% | 35,271 | +369.7% | 0.01% | +300.0% |
| Q1 2015 | $337,000 | -67.3% | 7,510 | -74.6% | 0.00% | -70.0% |
| Q3 2014 | $1,031,000 | -24.2% | 29,531 | -23.5% | 0.01% | -41.2% |
| Q2 2014 | $1,361,000 | -2.4% | 38,590 | -9.9% | 0.02% | -19.0% |
| Q1 2014 | $1,395,000 | – | 42,809 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bridge City Capital, LLC | 40,541 | $5,114,000 | 2.20% |
| Lisanti Capital Growth, LLC | 53,385 | $6,734,000 | 2.20% |
| Nitorum Capital, L.P. | 279,510 | $35,257,000 | 2.05% |
| CROWN ADVISORS MANAGEMENT, INC. | 20,000 | $2,523,000 | 1.69% |
| Millrace Asset Group, Inc. | 11,400 | $1,438,000 | 1.69% |
| COOKSON PEIRCE & CO INC | 145,884 | $18,402,000 | 1.61% |
| Endurant Capital Management LP | 32,594 | $4,111,000 | 1.48% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 111,000 | $14,002,000 | 1.38% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 110,065 | $13,884,000 | 1.37% |
| EMERALD ADVISERS, LLC | 203,640 | $25,687,000 | 1.20% |